Clinical Trials Directory

Trials / Completed

CompletedNCT02512354

Contribution of High-throughput Exome Sequencing in the Diagnosis of the Cause Fetal Polymalformation Syndromes

Contribution of High-throughput Exome Sequencing in Fetopathology

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This research concerns the contribution of a new examination, high-throughput exome sequencing, in the diagnosis of the cause of polymalformative fetal syndromes. With currently available examinations, the causes of polyformative syndromes, which correspond to the association of several congenital malformations with varying degrees of severity in different organs, remain unknown in a large number of cases. High-throughput exome sequencing (HTES) is a diagnostic tool that allows the simultaneous analysis of all of the coding parts of DNA. This examination has already shown its superior diagnostic capability in every post-natal diagnostic context, in particulier in infants with malformations associated or not with intellectual deficiency. Its contribution has not yet been studied in a large number of fetuses with polymalformations. To investigate the usefulness of HTES, we propose to carry out the examination in 100 fetuses with polymalformations, as well as the usual examinations including chromosomal microarray analysis and possibly the study of specific genes that may explain these malformations. A blood sample will be taken from both parents to allow interpretation of the results.

Conditions

Interventions

TypeNameDescription
OTHERSample of a fragment of fetal tissue
OTHERParent's blood samples

Timeline

Start date
2015-03-04
Primary completion
2018-10-08
Completion
2018-10-08
First posted
2015-07-30
Last updated
2026-02-09

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02512354. Inclusion in this directory is not an endorsement.